Blog
Addressing the Safety and Efficacy Aspects of COVID-19 Vaccines
One of the positives to emerge from our battle against COVID-19 has been public interest in vaccine development.
All Results
Blog
Newsletter
Industry Watch
In this third week of January, we bring our readers research updates on antibiotic resistance, and how in comparison, resistance to vaccines is rare.…
Fact Sheet
The Center for Vaccine Research Fact Sheet
PRA Health Sciences’ Center for Vaccine Research is a cross-divisional, highly experienced team dedicated to providing customized solutions and…
Blog
Ask the Experts Roundtable: Insights on Pfizer and Moderna’s Recent mRNA-Based Vaccine Developments
As the COVID-19 pandemic continues to challenge humankind worldwide, the medical industry and professionals alike are developing vaccines at…
Blog
Global Voices: How is COVID-19 Affecting Malawi?
COVID-19 hit the world on a massive scale. Despite its presence as a global issue, nations are each responding to the pandemic differently. Those…
Blog
Receiving Your Seasonal Flu Vaccine is Important to the Management of COVID-19
This influenza season, we will face two infectious diseases. The northern hemisphere is now entering the influenza (flu) season. Without a COVID-19…
Blog
A New Normal: How COVID-19 is Rapidly Changing Vaccine Development
COVID-19 is rapidly changing how industries around the world do business—especially drug development. From accelerated timelines to increased…
Blog
Ask the Experts: What do We Need to Know about Hepatitis and its Awareness?
Hepatitis is an inflammatory disease that affects the liver. Certain types can lead to liver cancer or even death. According to the World Health…
Blog
Ask the Experts: How has HIV Testing and Awareness Progressed?
Today, there are many treatments and preventions available for HIV. Data reveals that, across the US, there has been a 39% increase in the use of…
Case Study
Early Engagement Crucial to Develop Trial Design for Accelerated Schedule Vaccine Study
A case study describing PRA's involvement in an accelerated schedule vaccine study for poliomyelitis.